Bird & Bird advises Yokogawa on the acquisition of Insilico
Contacts
Bird & Bird has advised Yokogawa Electric Corporation on its acquisition of Insilico Biotechnology AG, a Stuttgart-based developer and provider of bioprocess software and services.
Advancing the bioeconomy is one of the main prioritised themes within Yokogawa's sustainability goals, and in line with this, the company intends to use the acquisition to develop comprehensive bioprocess solutions that support biopharmaceutical development and manufacturing. Insilico's innovative, clinically proven digital twin technology is expected to accelerate digital transformation in the bioprocess industry.
Yokogawa Electric Corporation was advised by the following Bird & Bird lawyers: partner Stephan Kübler, LL.M., associate Daniel Gloor, counsel Michael Gaßner, all corporate/M&A, partner Dr. René Voigtländer and associate Nina Rücker, both regulatory & administrative, partner Dr. Henriette Picot and associate Goekhan Kosak, both tech & comms/commercial, partner Dr. Ralph Panzer and associate Laura Schildberg, both employment, partner Dr. Christopher Maierhöfer and associate Dominik Igel, both patents, all Munich, partner Dr. Stephan Waldheim, EU & competition, Düsseldorf.